Hepatitis B infection in China

  • Lau G
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Chronic HBV infection is a serious health threat in the Asian-Pacific region. The introduction of lamivudine has greatly improved the hope of these patients and is undoubtly a milestone in the management of chronic HBV infection. The combination of lamivudine with another nucleotide or nucleoside analogue or immunomodulatory agent to improve its therapeutic efficacy further must be investigated. Also, the use of lamivudine to prevent HBV reactivation on withdrawal of immunosuppressive therapy should be explored

Author-supplied keywords

  • 2-Aminopurine
  • Adenine
  • Antiviral Agents
  • China
  • Deoxycytidine
  • Dna,Viral
  • Drug Therapy,Combination
  • Drugs,Chinese Herbal
  • Hepatitis
  • Hepatitis B
  • Hepatitis B Virus
  • Hepatitis B,Chronic
  • Human
  • Interferon-alpha
  • Lamivudine
  • Thymosin
  • analogs & derivatives
  • blood
  • drug effects
  • drug therapy
  • epidemiology
  • isolation & purification
  • pathology
  • therapeutic use
  • therapy
  • virology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 11385968


  • G K Lau

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free